ELUT compared with ABEO: revenue, margins and what each company keeps, and the suppliers and customers both name

ELUTElutia Inc.

Mkt capRevenueRevenue

ABEOAbeona Therapeutics Inc.

Mkt capRevenueRevenue

Compare

ELUTElutia Inc.

ABEOAbeona Therapeutics Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

ELUTElutia Inc.

0.84▲+2.89%· post 0.86

Mkt cap$37.1MRevenue$2MQ2 FY26

ABEOAbeona Therapeutics Inc.

4.34▼−4.83%· post 4.34

ClosedOct 30 '26

Mkt cap$248.8MRevenue$11MQ2 FY26

Compare

ClosedOct 30 '26

ELUTElutia Inc.

ABEOAbeona Therapeutics Inc.

0.84▲+2.89%post 0.86

Price

4.34▼−4.83%post 4.34

$37.1M

Mkt cap

$248.8M

Q2 FY26$2M

Revenue

$11MQ2 FY26

ELUT0.84▲+2.89%vsABEO4.34▼−4.83%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

ELUT, solidABEO, dashed

Supply-chain overlap

Revenue flow

ELUT: latest quarter is a loss; flow not drawable. ABEO: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ELUT 9

MDTMedtronic Sofamor Danek USAcustomer

BSXBoston Scientificcustomer

—Berkeleyunlistedsupplier

—Cookunlistedsupplier

5 more · ELUT chain ›

Shared 0

No shared counterparties.

Only ABEO 1

TSHATaysha Gene Therapiescustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR